click below
click below
Normal Size Small Size show me how
ID 4
| Brand | Generic | Pharmacologic Category | Indication | Essential Knowledge |
|---|---|---|---|---|
| Lamisil | terbinafine (PO. topical (OTC)) | Allylamine antifungal | Onychomycosis | Key Side Effects: nausea, abdominal pain, diarrhea, elevated hepatic transaminases, headache |
| Diflucan | fluconazole (PO, IV) | Azole antifungal | Vulvovaginal candidiasis, oropharyngeal candidiasis, invasive candidiasis | Key Side Effects: nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases |
| Nizoral | ketoconazole (PO, topical) | Azole antifungal | Tinea infections | nausea, abd pain, diarrhea, QTc prolongation, increased hepatic transaminases BW: serious hepatotoxicity, including cases w/ a fatal outcome/ requiring liver transplantation; may cause QTc prolongation and drug interactions leading to QTc prolongation |
| -- | nystatin (PO) | Polyene antifungal | Oropharyngeal candidiasis | Key Side Effects: phlebitis, diarrhea, vomiting, anemia, fever |
| Nystop | nystatin (topical) | Polyene antifungal | Cutaneous and mucocutaneous fungal infections | Key Side Effects: burning, itching Other Notes: only use oral solutions for thrush |
| Mycamine | micafungin (IV) | Echinocandin antifungal | invasive candidiases | Key Side Effects: no major side effects |
| Lotrisone | betamethasone and clotrimazole (topical) | Glucocorticoid and azole antifungal | Cutaneous fungal infections | Key Side Effects: burning, itching, dryness, skin atrophy Other Notes: do not use for diaper dermatitis; adrenal suppression with long-term use over large areas of skin |
| Tamiflu | oseltamivir (PO) | neuraminidase inhibitor antiviral | influenza | Key Side Effects: nausea, vomiting, neuropsychiatric events (i.e.,c onfusion, delirium, hallucinations) in pediatric patients (rare) |
| Zovirax | acyclovir (PO, IV) | antiviral | herpes simplex virus | Key Side Effects: nausea, increased hepatic transaminases, crystalluria Other Notes: vesicant |
| Valtrex | valacyclovir (PO) | antiviral | herpes simplex virus | Key Side Effects: nausea, increased hepatic transaminases |
| Paxlovid | nirmatrelvir + ritonavir (PO) | antiviral | COVID-19 | Key Side Effects: diarrhea, dysgeusia US Boxed Warning: significant drug interactions; strong CYP3A inhibitor |
| Veklury | remdesivir (IV) | antiviral | COVID-19 | Key Side Effects: hyperglycemia, renal impairment, bradycardia, increased liver enzymes, hypersensitivity |
| Truvada | emtricitabine + tenofovir disoproxil fumarate (PO) | nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) | HIV infection, PreP (pre-exposure prophylaxis), PEP (post-exposure prophylaxis) | Key Side Effects: decreased bone mineral density, kidney injury, nausea, diarrhea US Boxed Warnings: post treatment acute exacerbation of hepatitis B, risk of drug resistance with use for preexposure prophylaxis |
| Biktarvy | emtricitabine (NRTI) + tenofovir alafenamide (NRTI) + bictegravir (INSTI) | nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) and Integrase strand transfer inhibitor (INSTI) | HIV infection | SE: increased serum bilirubin, headache, weight gain, insomnia, diarrhea, nausea BW: post treatment acute exacerbation of hepatitis B Other Notes: take oral INSTIs 2 hours before or 6 hours after products containing Ca, Al, Mg, or Fe |